The Cannigma

SEPTEMBER 12, 2021

THC-O-acetate (THC-O or tetrahydrocannabinol acetate) is a synthetic cannabinoid said to be more potent and have longer-lasting effects than regular THC. This trending cannabinoid was first created sometime between 1955-1975 during the Edgewood military experiments. THC-O is a synthetic cannabinoid (Shutterstock).

THC 124

THC Cannabinoids Edibles DEA 124

SpeedWeed

AUGUST 8, 2021

Sativex (sold as nabiximols or Epidiolex in the United States) is manufactured by British company GW Pharmaceuticals, which received full federal approval in its home country for the drug back in 2010 for the treatment of multiple sclerosis. For years, such studies were largely blocked by prohibition-committed government entities. .

Cannabinoids 64

Cannabinoids Pharmaceutical DEA Medicine 64

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system.

CBD 105

CBD DEA Research and Development Hemp 105

Medicinal Genomics

NOVEMBER 5, 2019

Furthermore, the uppermost flower is typically the most cannabinoid-rich. Another potential headache for farmers is that analytical laboratories must be registered with the DEA in order to perform compliance testing. The USDA said they will provide a list of DEA-registered labs on their website, but nothing has been posted yet.

THC 81

THC Hemp DEA Banking 81

SpeedWeed

APRIL 27, 2021

Delta-8 THC, aka delta-8, the intoxicating cannabinoid synthesized from hemp, is making waves across the United States, and especially in states where marijuana remains illegal. Those court cases may help clear the legal air regarding the cannabinoid. Andrea Golan expects a federal response to delta-8 will first come from the DEA. “We

Legalization 52

Legalization DEA Supply Chain Hemp 52

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73